If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
Philips announced the debut of IntelliSpace Portal 10, the latest edition of its comprehensive, advanced visualization and quantification platform, at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago. This next generation features enhancements across the solution, with a particular focus on oncology to provide radiologists with an improved full set of applications and workflows to support the reading and follow-up of complex oncology cases. IntelliSpace Portal 10 also includes a new 3-D modeling application and has been expanded with the DynaCAD Prostate and Breast solutions through integration with InVivo.
At the 2017 Radiological Society of North America (RSNA) Annual Meeting, Philips unveiled the IQon Elite Spectral CT, designed to provide clinicians with increased diagnostic certainty in every scan. The system, a new configuration of the company's first spectral detector-based computed tomography (CT) scanner, debuts a suite of features that will enhance the clinical benefits of the IQon platform to improve diagnostic confidence while enhancing the patient experience, and supporting the needs of emergency/trauma and oncology care.
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next-generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians’ use of Azurion resulted in significant time savings for the hospital, including a 17 percent reduction of the average interventional procedure time, a 12 percent reduction of in-lab patient preparation time, and a 28 percent reduction of post-procedure lab time.
November 29, 2017 — Philips announced the introduction of IntelliSpace Enterprise Edition for Radiology, its ...
Philips announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians' use of Azurion resulted in significant time savings for the hospital, including a 17 percent reduction of the average interventional procedure time, a 12 percent reduction of in-lab patient preparation time, and a 28 percent reduction of post-procedure lab time.
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular imaging technology can guide prostate cancer surgery. The project will evaluate the imaging technology’s ability to detect prostate cancer during surgery, with the aim of performing more accurate removal of cancerous tissue.
Philips recently announced the key findings of its research focused on the patient experience in diagnostic imaging procedures. Philips’ Patient Experience in Imaging Study surveyed 603 patients in the United States and Germany about their satisfaction, expectations, preferences and unmet needs with diagnostic imaging procedures in the past year. Patients identified trust in the referring doctor, communication, comfort, safety and getting the image right the first time as key priorities. The research provides insight into how patients perceive imaging procedures, what they value during the process, and what healthcare professionals can do to create a more patient-centered imaging experience.
Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the new eL18-4 transducer with full solution for 'small parts' assessment. These ultrasound exams detect abnormalities in the small organs that are close to the skin. The Philips Ultimate Small Parts Solution features four key innovations that work together to help improve patient care: the eL18-4 PureWave linear array transducer, Philips MicroFlow Imaging, Philips Elastography and Philips Precision Biopsy. The new eL18-4 transducer can also be used to assess musculoskeletal injuries.
A battle is raging in imaging IT today. Once a profitable hunting ground for traditional picture archiving and communication system (PACS) firms, new market entrants from the content management, archiving and informatics market are looking to disrupt the status quo. Pushing “deconstruction,” “reconstruction” and “distributed” multi-vendor imaging IT models, they have grabbed the attention of healthcare providers.
Wide bore magnetic resonance imaging (MRI) systems have allowed radiologists to offer patients the optimized comfort of conventional open bore systems, as well as the high-quality imaging of conventional closed bore systems. Because wide bore MRIs have broadened the demographic of patients who can be tested, the systems have gained widespread adoption, with many practices opting to equip their offices solely with wide bore systems.